Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Ibrutinib> ?p ?o. }
Showing items 1 to 68 of
68
with 100 items per page.
- Ibrutinib abstract "Ibrutinib (USAN, also known as PCI-32765 and marketed in the U.S. under the name Imbruvica) is an anticancer drug targeting B-cell malignancies. It was approved by the US FDA in November 2013 for the treatment of mantle cell lymphoma and in February 2014 for the treatment of chronic lymphocytic leukemia. It is an orally-administered, selective and covalent inhibitor of the enzyme Bruton's tyrosine kinase (BTK). Ibrutinib is currently under development by Pharmacyclics, Inc and Johnson & Johnson's Janssen Pharmaceutical division for additional B-cell malignancies including diffuse large B-cell lymphoma and multiple myeloma.".
- Ibrutinib casNumber "936563-96-1".
- Ibrutinib chEBI "76612".
- Ibrutinib iupacName "1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one".
- Ibrutinib pubchem "24821094".
- Ibrutinib thumbnail Ibrutinib.svg?width=300.
- Ibrutinib wikiPageExternalLink ?CdrID=638648.
- Ibrutinib wikiPageExternalLink www.imbruvica.com.
- Ibrutinib wikiPageID "33997988".
- Ibrutinib wikiPageRevisionID "598714822".
- Ibrutinib c "25".
- Ibrutinib casNumber "936563".
- Ibrutinib chebi "76612".
- Ibrutinib chemspiderid "26637187".
- Ibrutinib eliminationHalfLife "-21600.0".
- Ibrutinib excretion "Faeces , urine".
- Ibrutinib h "24".
- Ibrutinib hasPhotoCollection Ibrutinib.
- Ibrutinib iupacName "1".
- Ibrutinib legalUs "Rx-only".
- Ibrutinib licenceUs "Ibrutinib".
- Ibrutinib metabolism "Hepatic".
- Ibrutinib molecularWeight "440.4971".
- Ibrutinib n "6".
- Ibrutinib o "2".
- Ibrutinib pregnancyUs "D".
- Ibrutinib proteinBound "97.3".
- Ibrutinib pubchem "24821094".
- Ibrutinib smiles "C=CCN1CCC[C@H]N2C3=CCN".
- Ibrutinib stdinchi "1".
- Ibrutinib stdinchikey "XYFPWWZEPKGCCK-GOSISDBHBU".
- Ibrutinib tradename "Imbruvica".
- Ibrutinib width "200".
- Ibrutinib subject Category:Experimental_cancer_drugs.
- Ibrutinib subject Category:Phenol_ethers.
- Ibrutinib subject Category:Piperidines.
- Ibrutinib subject Category:Tyrosine_kinase_inhibitors.
- Ibrutinib type Agent114778436.
- Ibrutinib type Antineoplastic102722458.
- Ibrutinib type CausalAgent100007347.
- Ibrutinib type CytotoxicDrug103157987.
- Ibrutinib type Drug103247620.
- Ibrutinib type ExperimentalCancerDrugs.
- Ibrutinib type Matter100020827.
- Ibrutinib type Medicine103740161.
- Ibrutinib type PhysicalEntity100001930.
- Ibrutinib type Substance100020090.
- Ibrutinib type TyrosineKinaseInhibitor104506005.
- Ibrutinib type TyrosineKinaseInhibitors.
- Ibrutinib type Drug.
- Ibrutinib type FunctionalSubstance.
- Ibrutinib comment "Ibrutinib (USAN, also known as PCI-32765 and marketed in the U.S. under the name Imbruvica) is an anticancer drug targeting B-cell malignancies. It was approved by the US FDA in November 2013 for the treatment of mantle cell lymphoma and in February 2014 for the treatment of chronic lymphocytic leukemia. It is an orally-administered, selective and covalent inhibitor of the enzyme Bruton's tyrosine kinase (BTK).".
- Ibrutinib label "Ibrutinib".
- Ibrutinib label "Ibrutinib".
- Ibrutinib label "Ibrutinib".
- Ibrutinib label "Ibrutinib".
- Ibrutinib sameAs Ibrutinib.
- Ibrutinib sameAs Ibrutinib.
- Ibrutinib sameAs Ibrutinib.
- Ibrutinib sameAs Ibrutinib.
- Ibrutinib sameAs m.0hr5hzf.
- Ibrutinib sameAs Q5984881.
- Ibrutinib sameAs Q5984881.
- Ibrutinib sameAs Ibrutinib.
- Ibrutinib wasDerivedFrom Ibrutinib?oldid=598714822.
- Ibrutinib depiction Ibrutinib.svg.
- Ibrutinib homepage www.imbruvica.com.
- Ibrutinib isPrimaryTopicOf Ibrutinib.